| SS-Chr 5BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
-7.39 |
null |
0.13 |
0.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55282 |
522 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
-6.78 |
null |
0.1 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55632 |
522 |
| SS-Chr 5BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
1.93 |
E-7mole |
0.35 |
0.98 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55901 |
522 |
| SS-Chr 5BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
9 |
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54908 |
522 |
| SS-Chr 5BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
7 |
1.59 |
mg/kg |
0.55 |
1.45 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
58901 |
526 |
| SS-Chr 5BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
1.52 |
E-7mole |
0.22 |
0.64 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56527 |
522 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
-6.87 |
null |
0.08 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56922 |
522 |
| SS-Chr 5BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
7 |
1.06 |
mg/kg |
0.12 |
0.32 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
58904 |
526 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
-6.88 |
null |
0.03 |
0.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56917 |
522 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
10 |
-7.52 |
null |
0.13 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55277 |
522 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
-7.06 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55627 |
522 |
| SS-Chr 5BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
0.98 |
E-7mole |
0.17 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55896 |
522 |
| SS-Chr 5BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
0.06 |
umol/l |
0.02 |
0.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54681 |
522 |
| SS-Chr 5BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
88.13 |
% |
6.08 |
17.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54787 |
522 |
| SS-Chr 5BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
1.34 |
E-7mole |
0.1 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56522 |
522 |
| SS-Chr 5BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
87.91 |
% |
3.41 |
11.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54782 |
522 |
| SS-Chr 5BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
91.8 |
% |
2.85 |
9.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57226 |
522 |
| SS-Chr 5BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
86.38 |
% |
8.85 |
25.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57231 |
522 |
| SS-Chr 5BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
8 |
1.2 |
mg/kg |
0.23 |
0.66 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
59176 |
526 |
| SS-Chr 5BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
9 |
0.97 |
mg/kg |
0.16 |
0.48 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
59180 |
526 |
| SS-Chr 5BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
7 |
0.05 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54913 |
522 |
| SS-Chr 5BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
10 |
0.04 |
umol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54676 |
522 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
9 |
-7.81 |
null |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56107 |
522 |
| SS-Chr 5BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
7 |
-7.35 |
null |
0.08 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56112 |
522 |